HEADER OXIDOREDUCTASE 13-DEC-02 1NF7 TITLE TERNARY COMPLEX OF THE HUMAN TYPE II INOSINE MONOPHOSPHATE TITLE 2 DEDHYDROGENASE WITH RIBAVIRIN MONOPHOSPHATE AND C2-MYCOPHENOLIC TITLE 3 ADENINE DINUCLEOTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: IMP DEHYDROGENASE 2, IMPDH-II, IMPD 2; COMPND 5 EC: 1.1.1.205; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IMPDH2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET12B KEYWDS 8 STRANDED PARALLE ALPHA/BETA BARREL, DEHYDROGENASE, IMPD, IMPDH, KEYWDS 2 RIBAVIRIN MONOPHOSPHATE, C2-MAD, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR D.RISAL,M.D.STRICKLER,B.M.GOLDSTEIN REVDAT 4 12-FEB-25 1NF7 1 COMPND HET HETNAM FORMUL REVDAT 4 2 1 ATOM REVDAT 3 16-AUG-23 1NF7 1 REMARK REVDAT 2 24-FEB-09 1NF7 1 VERSN REVDAT 1 27-JAN-04 1NF7 0 JRNL AUTH D.RISAL,M.D.STRICKLER,B.M.GOLDSTEIN JRNL TITL CRYSTAL STRUCTURE OF HUMAN INOSINE MONOPHOSPHATE JRNL TITL 2 DEHYDROGENASE TYPE II COMPLEXED WITH THE MPA/NAD ANALOG JRNL TITL 3 C2-MAD JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.24 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.100 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 64.7 REMARK 3 NUMBER OF REFLECTIONS : 25599 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.238 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2534 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.82 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 31.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1861 REMARK 3 BIN R VALUE (WORKING SET) : 0.3290 REMARK 3 BIN FREE R VALUE : 0.3700 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 198 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.026 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6880 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 141 REMARK 3 SOLVENT ATOMS : 93 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.80000 REMARK 3 B22 (A**2) : -8.80000 REMARK 3 B33 (A**2) : 17.60000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM SIGMAA (A) : 0.41 REMARK 3 LOW RESOLUTION CUTOFF (A) : 41.2 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.46 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.48 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.870 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 8.800 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 13.740; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 10.870; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 15.860; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 34.11 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : C2MAD_ENDO.PARAM REMARK 3 PARAMETER FILE 5 : RMP.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : RMP_C2EXO_PRODRG.TOP REMARK 3 TOPOLOGY FILE 3 : C2MAD_ENDO_VER1_1.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED. REMARK 3 THE RESIDUES LABELLED UNK 801 THROUGH 811 REPRESENT RESIDUES WHOSE REMARK 3 ELECTRON DENSITY IS ROBUST ENOUGH ONLY TO TRACE THE MAIN CHAIN. IT REMARK 3 IS NOT CLEAR HOW THESE ATOMS CORRESPOND TO THE SEQUENCE REMARK 3 ASSIGNMENT. THE CA ATOMS ARE INTENDED TO COMMUNICATE THE FACT THAT REMARK 3 THERE IS SIGNIFICANT DENSITY (VISIBLE AT 0.6 SIGMA OR LOWER) IN REMARK 3 THE REGION OF THE ACTIVE SITE THAT IS VERY NEAR TO THE BOUND REMARK 3 COFACTOR ANALOG AND THEREFORE POTENTIALLY MAKING INTERACTIONS WITH REMARK 3 THE ANALOG. REMARK 4 REMARK 4 1NF7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-DEC-02. REMARK 100 THE DEPOSITION ID IS D_1000017820. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-MAR-02 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : A1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.93 REMARK 200 MONOCHROMATOR : SILICON REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34951 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 41.240 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.0 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : 0.03800 REMARK 200 R SYM (I) : 0.03800 REMARK 200 FOR THE DATA SET : 16.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.72 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : 0.37100 REMARK 200 R SYM FOR SHELL (I) : 0.37100 REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: CHAIN A OF PDB ENTRY 1B3O REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 6% PEG 6000, 0.1M TRIS-HCL, 24MM BETA REMARK 280 -MERCAPTOETHANOL, 1M LICL, 10% GLYCEROL, PH 8.0, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 277.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 4 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z REMARK 290 4555 Y,-X,Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -Y+1/2,X+1/2,Z+1/2 REMARK 290 8555 Y+1/2,-X+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 73.29000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 73.29000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 64.46000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 73.29000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 73.29000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 64.46000 REMARK 290 SMTRY1 7 0.000000 -1.000000 0.000000 73.29000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 73.29000 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 64.46000 REMARK 290 SMTRY1 8 0.000000 1.000000 0.000000 73.29000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 73.29000 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 64.46000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 146.58000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 146.58000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 -1.000000 0.000000 146.58000 REMARK 350 BIOMT2 3 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 -1.000000 0.000000 0.000000 146.58000 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 146.58000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 146.58000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 -1.000000 0.000000 146.58000 REMARK 350 BIOMT2 3 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 -1.000000 0.000000 0.000000 146.58000 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ASP A 3 REMARK 465 TYR A 4 REMARK 465 LEU A 5 REMARK 465 ILE A 6 REMARK 465 SER A 7 REMARK 465 GLY A 8 REMARK 465 GLY A 9 REMARK 465 ASP A 125 REMARK 465 ARG A 126 REMARK 465 VAL A 127 REMARK 465 ARG A 128 REMARK 465 ASP A 129 REMARK 465 VAL A 130 REMARK 465 PHE A 131 REMARK 465 GLU A 132 REMARK 465 ALA A 133 REMARK 465 LYS A 134 REMARK 465 ALA A 135 REMARK 465 ARG A 136 REMARK 465 HIS A 137 REMARK 465 GLY A 138 REMARK 465 PHE A 139 REMARK 465 CYS A 140 REMARK 465 GLY A 141 REMARK 465 ILE A 142 REMARK 465 PRO A 143 REMARK 465 ILE A 144 REMARK 465 THR A 145 REMARK 465 ASP A 146 REMARK 465 THR A 147 REMARK 465 GLY A 148 REMARK 465 ARG A 149 REMARK 465 MET A 150 REMARK 465 GLY A 151 REMARK 465 SER A 152 REMARK 465 ARG A 153 REMARK 465 LEU A 154 REMARK 465 VAL A 155 REMARK 465 LYS A 167 REMARK 465 GLU A 168 REMARK 465 GLU A 169 REMARK 465 ASP A 226 REMARK 465 ASP A 421 REMARK 465 LYS A 422 REMARK 465 HIS A 423 REMARK 465 LEU A 424 REMARK 465 SER A 425 REMARK 465 SER A 426 REMARK 465 GLN A 427 REMARK 465 ASN A 428 REMARK 465 ARG A 429 REMARK 465 TYR A 430 REMARK 465 PHE A 431 REMARK 465 SER A 432 REMARK 465 GLU A 433 REMARK 465 ALA A 434 REMARK 465 ASP A 435 REMARK 465 LYS A 436 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 ASP B 3 REMARK 465 TYR B 4 REMARK 465 LEU B 5 REMARK 465 ILE B 6 REMARK 465 SER B 7 REMARK 465 GLY B 8 REMARK 465 GLY B 9 REMARK 465 ASP B 125 REMARK 465 ARG B 126 REMARK 465 VAL B 127 REMARK 465 ARG B 128 REMARK 465 ASP B 129 REMARK 465 VAL B 130 REMARK 465 PHE B 131 REMARK 465 GLU B 132 REMARK 465 ALA B 133 REMARK 465 LYS B 134 REMARK 465 ALA B 135 REMARK 465 ARG B 136 REMARK 465 HIS B 137 REMARK 465 GLY B 138 REMARK 465 PHE B 139 REMARK 465 CYS B 140 REMARK 465 GLY B 141 REMARK 465 ILE B 142 REMARK 465 PRO B 143 REMARK 465 ILE B 144 REMARK 465 THR B 145 REMARK 465 ASP B 146 REMARK 465 THR B 147 REMARK 465 GLY B 148 REMARK 465 ARG B 149 REMARK 465 MET B 150 REMARK 465 GLY B 151 REMARK 465 SER B 152 REMARK 465 ARG B 153 REMARK 465 LEU B 154 REMARK 465 VAL B 155 REMARK 465 LYS B 167 REMARK 465 GLU B 168 REMARK 465 GLU B 169 REMARK 465 ASP B 226 REMARK 465 ASP B 421 REMARK 465 LYS B 422 REMARK 465 HIS B 423 REMARK 465 LEU B 424 REMARK 465 SER B 425 REMARK 465 SER B 426 REMARK 465 GLN B 427 REMARK 465 ASN B 428 REMARK 465 ARG B 429 REMARK 465 TYR B 430 REMARK 465 PHE B 431 REMARK 465 SER B 432 REMARK 465 GLU B 433 REMARK 465 ALA B 434 REMARK 465 ASP B 435 REMARK 465 LYS B 436 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ILE B 437 CB - CG1 - CD1 ANGL. DEV. = -24.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 12 -63.43 -104.40 REMARK 500 VAL A 13 110.60 63.24 REMARK 500 PRO A 14 -169.98 -59.85 REMARK 500 ASP A 15 62.16 -109.85 REMARK 500 GLN A 21 -74.87 -38.57 REMARK 500 CYS A 26 -70.88 -114.11 REMARK 500 ASP A 43 45.19 -148.66 REMARK 500 ASP A 71 8.91 -61.62 REMARK 500 VAL A 73 -61.68 -124.37 REMARK 500 ALA A 76 -75.46 15.75 REMARK 500 CYS A 95 145.85 172.89 REMARK 500 GLN A 112 135.43 -38.38 REMARK 500 THR A 116 -90.61 -43.36 REMARK 500 ILE A 157 171.90 -57.28 REMARK 500 ILE A 158 76.40 -150.34 REMARK 500 SER A 160 -41.02 -21.71 REMARK 500 ARG A 161 -69.28 -26.68 REMARK 500 ILE A 163 -42.30 -27.77 REMARK 500 ASP A 164 -84.25 -60.48 REMARK 500 HIS A 171 83.40 -63.90 REMARK 500 ASP A 172 161.78 -46.51 REMARK 500 CYS A 173 103.86 -49.85 REMARK 500 PHE A 174 170.48 49.64 REMARK 500 ILE A 178 9.92 -61.41 REMARK 500 MET A 179 83.66 -162.66 REMARK 500 THR A 180 76.77 -100.31 REMARK 500 ARG A 182 144.09 -37.41 REMARK 500 ASP A 184 88.06 -67.23 REMARK 500 LYS A 195 -73.75 -63.55 REMARK 500 ALA A 197 -92.18 -45.41 REMARK 500 LYS A 205 28.34 43.60 REMARK 500 LYS A 208 62.91 -164.47 REMARK 500 ASN A 213 -80.71 -69.29 REMARK 500 GLU A 214 -38.34 -148.99 REMARK 500 ASP A 215 59.00 -91.43 REMARK 500 ASP A 216 48.35 16.54 REMARK 500 LEU A 218 108.65 -25.67 REMARK 500 LYS A 229 66.28 178.06 REMARK 500 ASN A 230 138.66 -39.80 REMARK 500 ARG A 231 -164.65 -79.19 REMARK 500 ALA A 236 135.13 -33.88 REMARK 500 LYS A 241 21.11 -73.87 REMARK 500 LYS A 242 16.49 58.59 REMARK 500 ASP A 255 12.37 -60.17 REMARK 500 ALA A 266 -1.01 -58.85 REMARK 500 LEU A 337 -100.44 -129.25 REMARK 500 ALA A 338 -6.83 163.84 REMARK 500 ARG A 356 4.94 -62.76 REMARK 500 ALA A 363 97.66 -69.84 REMARK 500 LEU A 389 5.06 -64.07 REMARK 500 REMARK 500 THIS ENTRY HAS 114 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 K A 902 K REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLY A 328 O REMARK 620 2 CYS A 331 O 69.3 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 K B 901 K REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLY B 328 O REMARK 620 2 CYS B 331 O 68.2 REMARK 620 N 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE K B 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE K A 902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RVP A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MYD A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RVP B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MYD B 702 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1B3O RELATED DB: PDB REMARK 900 THE SAME ENZYME COMPLEXED WITH 6CL-IMP AND SELENAZOFURIN ADENINE REMARK 900 DINUCLEOTIDE (SAD). REMARK 900 RELATED ID: 1NFB RELATED DB: PDB DBREF 1NF7 A 1 514 UNP P12268 IMD2_HUMAN 1 514 DBREF 1NF7 B 1 514 UNP P12268 IMD2_HUMAN 1 514 SEQRES 1 A 514 MET ALA ASP TYR LEU ILE SER GLY GLY THR SER TYR VAL SEQRES 2 A 514 PRO ASP ASP GLY LEU THR ALA GLN GLN LEU PHE ASN CYS SEQRES 3 A 514 GLY ASP GLY LEU THR TYR ASN ASP PHE LEU ILE LEU PRO SEQRES 4 A 514 GLY TYR ILE ASP PHE THR ALA ASP GLN VAL ASP LEU THR SEQRES 5 A 514 SER ALA LEU THR LYS LYS ILE THR LEU LYS THR PRO LEU SEQRES 6 A 514 VAL SER SER PRO MET ASP THR VAL THR GLU ALA GLY MET SEQRES 7 A 514 ALA ILE ALA MET ALA LEU THR GLY GLY ILE GLY PHE ILE SEQRES 8 A 514 HIS HIS ASN CYS THR PRO GLU PHE GLN ALA ASN GLU VAL SEQRES 9 A 514 ARG LYS VAL LYS LYS TYR GLU GLN GLY PHE ILE THR ASP SEQRES 10 A 514 PRO VAL VAL LEU SER PRO LYS ASP ARG VAL ARG ASP VAL SEQRES 11 A 514 PHE GLU ALA LYS ALA ARG HIS GLY PHE CYS GLY ILE PRO SEQRES 12 A 514 ILE THR ASP THR GLY ARG MET GLY SER ARG LEU VAL GLY SEQRES 13 A 514 ILE ILE SER SER ARG ASP ILE ASP PHE LEU LYS GLU GLU SEQRES 14 A 514 GLU HIS ASP CYS PHE LEU GLU GLU ILE MET THR LYS ARG SEQRES 15 A 514 GLU ASP LEU VAL VAL ALA PRO ALA GLY ILE THR LEU LYS SEQRES 16 A 514 GLU ALA ASN GLU ILE LEU GLN ARG SER LYS LYS GLY LYS SEQRES 17 A 514 LEU PRO ILE VAL ASN GLU ASP ASP GLU LEU VAL ALA ILE SEQRES 18 A 514 ILE ALA ARG THR ASP LEU LYS LYS ASN ARG ASP TYR PRO SEQRES 19 A 514 LEU ALA SER LYS ASP ALA LYS LYS GLN LEU LEU CYS GLY SEQRES 20 A 514 ALA ALA ILE GLY THR HIS GLU ASP ASP LYS TYR ARG LEU SEQRES 21 A 514 ASP LEU LEU ALA GLN ALA GLY VAL ASP VAL VAL VAL LEU SEQRES 22 A 514 ASP SER SER GLN GLY ASN SER ILE PHE GLN ILE ASN MET SEQRES 23 A 514 ILE LYS TYR ILE LYS ASP LYS TYR PRO ASN LEU GLN VAL SEQRES 24 A 514 ILE GLY GLY ASN VAL VAL THR ALA ALA GLN ALA LYS ASN SEQRES 25 A 514 LEU ILE ASP ALA GLY VAL ASP ALA LEU ARG VAL GLY MET SEQRES 26 A 514 GLY SER GLY SER ILE CYS ILE THR GLN GLU VAL LEU ALA SEQRES 27 A 514 CYS GLY ARG PRO GLN ALA THR ALA VAL TYR LYS VAL SER SEQRES 28 A 514 GLU TYR ALA ARG ARG PHE GLY VAL PRO VAL ILE ALA ASP SEQRES 29 A 514 GLY GLY ILE GLN ASN VAL GLY HIS ILE ALA LYS ALA LEU SEQRES 30 A 514 ALA LEU GLY ALA SER THR VAL MET MET GLY SER LEU LEU SEQRES 31 A 514 ALA ALA THR THR GLU ALA PRO GLY GLU TYR PHE PHE SER SEQRES 32 A 514 ASP GLY ILE ARG LEU LYS LYS TYR ARG GLY MET GLY SER SEQRES 33 A 514 LEU ASP ALA MET ASP LYS HIS LEU SER SER GLN ASN ARG SEQRES 34 A 514 TYR PHE SER GLU ALA ASP LYS ILE LYS VAL ALA GLN GLY SEQRES 35 A 514 VAL SER GLY ALA VAL GLN ASP LYS GLY SER ILE HIS LYS SEQRES 36 A 514 PHE VAL PRO TYR LEU ILE ALA GLY ILE GLN HIS SER CYS SEQRES 37 A 514 GLN ASP ILE GLY ALA LYS SER LEU THR GLN VAL ARG ALA SEQRES 38 A 514 MET MET TYR SER GLY GLU LEU LYS PHE GLU LYS ARG THR SEQRES 39 A 514 SER SER ALA GLN VAL GLU GLY GLY VAL HIS SER LEU HIS SEQRES 40 A 514 SER TYR GLU LYS ARG LEU PHE SEQRES 1 B 514 MET ALA ASP TYR LEU ILE SER GLY GLY THR SER TYR VAL SEQRES 2 B 514 PRO ASP ASP GLY LEU THR ALA GLN GLN LEU PHE ASN CYS SEQRES 3 B 514 GLY ASP GLY LEU THR TYR ASN ASP PHE LEU ILE LEU PRO SEQRES 4 B 514 GLY TYR ILE ASP PHE THR ALA ASP GLN VAL ASP LEU THR SEQRES 5 B 514 SER ALA LEU THR LYS LYS ILE THR LEU LYS THR PRO LEU SEQRES 6 B 514 VAL SER SER PRO MET ASP THR VAL THR GLU ALA GLY MET SEQRES 7 B 514 ALA ILE ALA MET ALA LEU THR GLY GLY ILE GLY PHE ILE SEQRES 8 B 514 HIS HIS ASN CYS THR PRO GLU PHE GLN ALA ASN GLU VAL SEQRES 9 B 514 ARG LYS VAL LYS LYS TYR GLU GLN GLY PHE ILE THR ASP SEQRES 10 B 514 PRO VAL VAL LEU SER PRO LYS ASP ARG VAL ARG ASP VAL SEQRES 11 B 514 PHE GLU ALA LYS ALA ARG HIS GLY PHE CYS GLY ILE PRO SEQRES 12 B 514 ILE THR ASP THR GLY ARG MET GLY SER ARG LEU VAL GLY SEQRES 13 B 514 ILE ILE SER SER ARG ASP ILE ASP PHE LEU LYS GLU GLU SEQRES 14 B 514 GLU HIS ASP CYS PHE LEU GLU GLU ILE MET THR LYS ARG SEQRES 15 B 514 GLU ASP LEU VAL VAL ALA PRO ALA GLY ILE THR LEU LYS SEQRES 16 B 514 GLU ALA ASN GLU ILE LEU GLN ARG SER LYS LYS GLY LYS SEQRES 17 B 514 LEU PRO ILE VAL ASN GLU ASP ASP GLU LEU VAL ALA ILE SEQRES 18 B 514 ILE ALA ARG THR ASP LEU LYS LYS ASN ARG ASP TYR PRO SEQRES 19 B 514 LEU ALA SER LYS ASP ALA LYS LYS GLN LEU LEU CYS GLY SEQRES 20 B 514 ALA ALA ILE GLY THR HIS GLU ASP ASP LYS TYR ARG LEU SEQRES 21 B 514 ASP LEU LEU ALA GLN ALA GLY VAL ASP VAL VAL VAL LEU SEQRES 22 B 514 ASP SER SER GLN GLY ASN SER ILE PHE GLN ILE ASN MET SEQRES 23 B 514 ILE LYS TYR ILE LYS ASP LYS TYR PRO ASN LEU GLN VAL SEQRES 24 B 514 ILE GLY GLY ASN VAL VAL THR ALA ALA GLN ALA LYS ASN SEQRES 25 B 514 LEU ILE ASP ALA GLY VAL ASP ALA LEU ARG VAL GLY MET SEQRES 26 B 514 GLY SER GLY SER ILE CYS ILE THR GLN GLU VAL LEU ALA SEQRES 27 B 514 CYS GLY ARG PRO GLN ALA THR ALA VAL TYR LYS VAL SER SEQRES 28 B 514 GLU TYR ALA ARG ARG PHE GLY VAL PRO VAL ILE ALA ASP SEQRES 29 B 514 GLY GLY ILE GLN ASN VAL GLY HIS ILE ALA LYS ALA LEU SEQRES 30 B 514 ALA LEU GLY ALA SER THR VAL MET MET GLY SER LEU LEU SEQRES 31 B 514 ALA ALA THR THR GLU ALA PRO GLY GLU TYR PHE PHE SER SEQRES 32 B 514 ASP GLY ILE ARG LEU LYS LYS TYR ARG GLY MET GLY SER SEQRES 33 B 514 LEU ASP ALA MET ASP LYS HIS LEU SER SER GLN ASN ARG SEQRES 34 B 514 TYR PHE SER GLU ALA ASP LYS ILE LYS VAL ALA GLN GLY SEQRES 35 B 514 VAL SER GLY ALA VAL GLN ASP LYS GLY SER ILE HIS LYS SEQRES 36 B 514 PHE VAL PRO TYR LEU ILE ALA GLY ILE GLN HIS SER CYS SEQRES 37 B 514 GLN ASP ILE GLY ALA LYS SER LEU THR GLN VAL ARG ALA SEQRES 38 B 514 MET MET TYR SER GLY GLU LEU LYS PHE GLU LYS ARG THR SEQRES 39 B 514 SER SER ALA GLN VAL GLU GLY GLY VAL HIS SER LEU HIS SEQRES 40 B 514 SER TYR GLU LYS ARG LEU PHE HET K A 902 1 HET RVP A 600 21 HET MYD A 701 43 HET K B 901 1 HET RVP B 601 21 HET MYD B 702 43 HET UNL B 801 1 HET UNL B 802 1 HET UNL B 803 1 HET UNL B 804 1 HET UNL B 805 1 HET UNL B 806 1 HET UNL B 807 1 HET UNL B 808 1 HET UNL B 809 1 HET UNL B 810 1 HET UNL B 811 1 HETNAM K POTASSIUM ION HETNAM RVP RIBAVIRIN MONOPHOSPHATE HETNAM MYD {[5-(6-AMINO-PURIN-7-YL)-3,4-DIHYDROXY-TETRAHYDRO- HETNAM 2 MYD FURAN-2-YLMETHOXY]-HYDROXY-PHOSPHORYLMETHYL}- HETNAM 3 MYD PHOSPHONIC ACID MONO-[2-(4-HYDROXY-6-METHOXY-7-METHYL- HETNAM 4 MYD 3-OXO-1,3-DIHYDRO-ISOBENZOFURAN-5-YL)-ETHYL] ESTER HETNAM UNL UNKNOWN LIGAND HETSYN MYD C2-MYCOPHENOLIC ADENINE DINUCLEOTIDE FORMUL 3 K 2(K 1+) FORMUL 4 RVP 2(C8 H13 N4 O8 P) FORMUL 5 MYD 2(C23 H29 N5 O13 P2) FORMUL 20 HOH *93(H2 O) HELIX 1 1 THR A 19 ASN A 25 1 7 HELIX 2 2 THR A 31 ASN A 33 5 3 HELIX 3 3 THR A 45 VAL A 49 5 5 HELIX 4 4 ALA A 76 GLY A 86 1 11 HELIX 5 5 THR A 96 LYS A 109 1 14 HELIX 6 6 SER A 160 PHE A 165 1 6 HELIX 7 7 THR A 193 SER A 204 1 12 HELIX 8 8 ASP A 255 ALA A 266 1 12 HELIX 9 9 SER A 280 TYR A 294 1 15 HELIX 10 10 THR A 306 GLY A 317 1 12 HELIX 11 11 ILE A 332 LEU A 337 1 6 HELIX 12 12 PRO A 342 ARG A 355 1 14 HELIX 13 13 ARG A 356 GLY A 358 5 3 HELIX 14 14 ASN A 369 LEU A 379 1 11 HELIX 15 15 GLY A 387 ALA A 391 5 5 HELIX 16 16 SER A 452 GLY A 472 1 21 HELIX 17 17 SER A 475 SER A 485 1 11 HELIX 18 18 THR A 494 GLY A 502 1 9 HELIX 19 19 THR B 19 ASN B 25 1 7 HELIX 20 20 THR B 31 ASN B 33 5 3 HELIX 21 21 THR B 45 VAL B 49 5 5 HELIX 22 22 ALA B 76 GLY B 86 1 11 HELIX 23 23 THR B 96 LYS B 109 1 14 HELIX 24 24 SER B 160 PHE B 165 1 6 HELIX 25 25 THR B 193 SER B 204 1 12 HELIX 26 26 ASP B 255 ALA B 266 1 12 HELIX 27 27 SER B 280 TYR B 294 1 15 HELIX 28 28 THR B 306 GLY B 317 1 12 HELIX 29 29 ILE B 332 LEU B 337 1 6 HELIX 30 30 PRO B 342 ARG B 355 1 14 HELIX 31 31 ARG B 356 GLY B 358 5 3 HELIX 32 32 ASN B 369 LEU B 379 1 11 HELIX 33 33 GLY B 387 ALA B 391 5 5 HELIX 34 34 SER B 452 GLY B 472 1 21 HELIX 35 35 SER B 475 SER B 485 1 11 HELIX 36 36 THR B 494 GLY B 502 1 9 SHEET 1 A 2 PHE A 35 ILE A 37 0 SHEET 2 A 2 PHE A 490 LYS A 492 -1 O GLU A 491 N LEU A 36 SHEET 1 B 2 SER A 53 ALA A 54 0 SHEET 2 B 2 THR A 60 LEU A 61 -1 O LEU A 61 N SER A 53 SHEET 1 C 8 LEU A 65 SER A 67 0 SHEET 2 C 8 THR A 383 MET A 386 1 O MET A 386 N VAL A 66 SHEET 3 C 8 VAL A 361 ASP A 364 1 N ALA A 363 O THR A 383 SHEET 4 C 8 ALA A 320 VAL A 323 1 N LEU A 321 O ILE A 362 SHEET 5 C 8 GLN A 298 VAL A 304 1 N GLY A 301 O ALA A 320 SHEET 6 C 8 VAL A 270 LEU A 273 1 N VAL A 271 O ILE A 300 SHEET 7 C 8 GLY A 247 ILE A 250 1 N ILE A 250 O VAL A 272 SHEET 8 C 8 PHE A 90 ILE A 91 1 N ILE A 91 O ALA A 249 SHEET 1 D 2 PRO A 210 ILE A 211 0 SHEET 2 D 2 ALA A 220 ILE A 221 -1 O ALA A 220 N ILE A 211 SHEET 1 E 2 LYS A 409 ARG A 412 0 SHEET 2 E 2 SER A 444 VAL A 447 -1 O GLY A 445 N TYR A 411 SHEET 1 F 2 PHE B 35 ILE B 37 0 SHEET 2 F 2 PHE B 490 LYS B 492 -1 O GLU B 491 N LEU B 36 SHEET 1 G 2 SER B 53 ALA B 54 0 SHEET 2 G 2 THR B 60 LEU B 61 -1 O LEU B 61 N SER B 53 SHEET 1 H 8 LEU B 65 SER B 67 0 SHEET 2 H 8 THR B 383 MET B 386 1 O MET B 386 N VAL B 66 SHEET 3 H 8 VAL B 361 ASP B 364 1 N ALA B 363 O THR B 383 SHEET 4 H 8 ALA B 320 VAL B 323 1 N LEU B 321 O ILE B 362 SHEET 5 H 8 GLN B 298 VAL B 304 1 N GLY B 301 O ALA B 320 SHEET 6 H 8 VAL B 270 LEU B 273 1 N VAL B 271 O ILE B 300 SHEET 7 H 8 GLY B 247 ILE B 250 1 N ILE B 250 O VAL B 272 SHEET 8 H 8 PHE B 90 ILE B 91 1 N ILE B 91 O ALA B 249 SHEET 1 I 2 PRO B 210 ILE B 211 0 SHEET 2 I 2 ALA B 220 ILE B 221 -1 O ALA B 220 N ILE B 211 SHEET 1 J 2 LYS B 409 ARG B 412 0 SHEET 2 J 2 SER B 444 VAL B 447 -1 O GLY B 445 N TYR B 411 LINK O GLY A 328 K K A 902 1555 1555 2.90 LINK O CYS A 331 K K A 902 1555 1555 2.75 LINK O GLY B 328 K K B 901 1555 1555 2.96 LINK O CYS B 331 K K B 901 1555 1555 2.80 SITE 1 AC1 7 GLY B 326 GLY B 328 CYS B 331 GLU B 500 SITE 2 AC1 7 GLY B 501 GLY B 502 HOH B 947 SITE 1 AC2 6 GLY A 326 GLY A 328 CYS A 331 GLU A 500 SITE 2 AC2 6 GLY A 501 GLY A 502 SITE 1 AC3 22 SER A 68 MET A 70 ASN A 303 ARG A 322 SITE 2 AC3 22 GLY A 328 SER A 329 ILE A 330 CYS A 331 SITE 3 AC3 22 ASP A 364 GLY A 365 GLY A 366 GLY A 387 SITE 4 AC3 22 SER A 388 TYR A 411 GLY A 413 MET A 414 SITE 5 AC3 22 GLY A 415 GLN A 441 GLY A 442 MYD A 701 SITE 6 AC3 22 HOH A 907 HOH A 942 SITE 1 AC4 18 THR A 252 HIS A 253 ASP A 274 SER A 275 SITE 2 AC4 18 SER A 276 PHE A 282 ASN A 303 ARG A 322 SITE 3 AC4 18 GLY A 324 MET A 325 GLY A 326 CYS A 331 SITE 4 AC4 18 THR A 333 GLN A 441 GLN A 469 RVP A 600 SITE 5 AC4 18 HOH A 941 HOH A 948 SITE 1 AC5 24 SER B 68 MET B 70 ASN B 303 ARG B 322 SITE 2 AC5 24 GLY B 328 SER B 329 ILE B 330 CYS B 331 SITE 3 AC5 24 ASP B 364 GLY B 365 GLY B 366 GLY B 387 SITE 4 AC5 24 SER B 388 TYR B 411 GLY B 413 MET B 414 SITE 5 AC5 24 GLY B 415 GLN B 441 GLY B 442 MYD B 702 SITE 6 AC5 24 HOH B 918 HOH B 919 HOH B 922 HOH B 939 SITE 1 AC6 19 THR B 252 ASP B 274 SER B 275 SER B 276 SITE 2 AC6 19 PHE B 282 ASN B 303 ARG B 322 GLY B 324 SITE 3 AC6 19 MET B 325 GLY B 326 CYS B 331 THR B 333 SITE 4 AC6 19 GLN B 441 GLN B 469 RVP B 601 HOH B 922 SITE 5 AC6 19 HOH B 938 HOH B 942 HOH B 948 CRYST1 146.580 146.580 128.920 90.00 90.00 90.00 I 4 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006822 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006822 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007757 0.00000